This week, we’ll talk with Abbott’s medical devices EVP Lisa Earnhardt about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the lockdown’s impact became clear and why the company performed so well in one of its key businesses. We also explore this week’s news that […]
Corindus Vascular Robotics
12 surgical robotics companies you need to know
Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a […]
Medtechs can’t set digital strategies aside – DTW Podcast
Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck. In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices. Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical, […]
Former Corindus CEO Toland joins robotic `micro’ surgical startup
Mark Toland, the former CEO of Corindus Vascular Robotics, believes the next big opportunity for surgical robotics is actually very small. Toland, who sold the telesurgery robotics company to Siemens in 2019 for $1.1 billion, is now the CEO of Medical Microinstruments S.p.A. (MMI), an Italian company that has developed a surgical robotic system capable […]
Corindus wins FDA clearance for robotic surgery automation tech
Corindus Vascular Robotics announced today that it launched a new set of automated robotic movements in its technIQ series for the CorPath GRX. Waltham, Mass.-based Corindus received FDA 510(k) clearance for a new software automation designed to provide predictable and consistent movements for advanced device manipulation during complex coronary peripheral procedures, according to a news […]
DTW Podcast: 3 lessons learned from Leslie Trigg, CEO of Outset Medical
Outset Medical (NSDQ:OM) CEO Leslie Trigg took the helm at the dialysis start-up in 2013, moving from an executive-in-residence post at private equity firm Warburg Pincus. Before that she held senior positions at Lutonix, AccessClosure and FoxHollow, helping to position those companies to be acquired by CR Bard, Cardinal Health, and ev3/Covidien, respectively. This week, […]
Former Corindus CEO Toland joins medtech investment firm
BioStar Capital announced today that former Corindus Vascular Robotics CEO Mark Toland has joined the firm as a partner and EIR. As a partner and entrepreneur in residence (EIR), Toland is slated to help in the discovery, development and nurturing of new startups with high-growth potential. He will also have the flexibility to function in […]
Report: Mayo Clinic to try Corindus telestenting
Mayo Clinic researchers this spring plan to try out Corindus’ telestenting technology — which Mayo officials think could improve care in the rural hospitals in their network, according to a report in the Star Tribune of Minneapolis. Corindus told MassDevice‘s sister site Medical Design & Outsourcing in 2018 that the company had a partnership with […]
Siemens Healthineers closes $1B Corindus Vascular Robotics buy
Siemens Healthineers said it today completed its $1.1 billion buyout of Corindus Vascular Robotics and its robot-assisted device for coronary and peripheral vascular procedures. Last week Corindus shareholders approved the merger, in which the German firm put up $4.28 per common share and $85.60 per Series A convertible preferred share. Today Siemens Healthineers said former […]
Corindus Vascular Robotics shareholders OK $1B Siemens Healthineers takeover
Corindus Vascular Robotics (NYSE:CVRS) said today that its stockholders approved the adoption of a $1.1 billion merger with with Siemens (NYSE:SI). Waltham, Mass.-based Corindus said the transaction is slated to close Oct. 29, after which Corindus will be delisted from the New York Stock Exchange, according to a news release. Corindus stockholders are set to receive $4.28 per […]
Corindus looks to forestall investor suits ahead of $1B Siemens buyout
Corindus Vascular Robotics (NYSE:CVRS) moved to forestall a group of lawsuits brought over its pending $1.1 billion merger with Siemens Healthineers (NYSE:SI). Corindus announced August 9 that it was set to be acquired by Siemens in an all-cash deal for $4.28 per CVRS share. The announcement prompted six lawsuits alleging that Corindus provided incomplete and misleading financial projections […]
